Eprazinone
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162710This classification denotes a mucolytic agent and expectorant with the molecular formula C24H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 883YNL63WU, chemically known as 1-propanone, 3-(4-(2-ethoxy-2-phenylethyl)-1-piperazinyl)-2-methyl-1-phenyl- but more generally known as eprazinone, which bears US NIH Compound Identifier 3245. European Medicines Agency schedules Eprazinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06583MIG. The term EPRAZINONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules eprazinone in its Anatomical Therapeutic Chemical (ATC) Classification. EPRAZINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule eprazinone under HS 29335995 and SITC 51576. As of Q4 2014, EPRAZINONE remains US FDA's Preferred Term for this commodity. Eprazinone bears US NLM identifiers UMLS ID C0059469 and NCI Concept Code C65518. SMILES: O(C(CN1CCN(CC1)CC(C)C(=O)C1CCCCC1)C1CCCCC1)CC.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.